Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
Rommel Zambrano-Huailla; Laura Guedes; Jose Tadeu Stefano; Arthur A. Arrais de Souza; Sebastián Marciano; Erika Yvamoto; Matheus Truccolo Michalczuk; Denise Siqueira Vanni; Hernan Rodriguez; Flair Jose Carrilho; Mario Reis Alvares-da-Silva; Adrian Gadano; Marco Arrese; Adelina Lozano Miranda; Claudia P. Oliveira;
Ann Hepatol. 2020;19:622-6
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population
Shi-En Chong; Felicia Chang; Kee-Huat Chuah; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva; Wah-Kheong Chan;
Ann Hepatol. 2023;28:
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study
Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28: